comparemela.com

Latest Breaking News On - Teva active pharmaceutical ingredients - Page 1 : comparemela.com

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business

TEL AVIV, Israel (BUSINESS WIRE) Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be base.

Teva beats on Q3 revenue and raises guidance

The Israeli pharmaceutical company will return to revenue growth after five years in which its revenue has shrunk.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.